β-Blocker in Congestive Heart Failure: The Pharmacology of Caronvedilol, a Vasodilating β-Blocker and Antioxidant, and Its Therapeutic Utility in Congestive Heart Failure

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 611-615

  Feuerstein, Gloria ^a   Ruffolo Jr , Robert R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956748322     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60825-X     Document Type: Article

References (9)

1. Waagstein F., Hjalmarson A., Varnauskas E., and Wallentin I. Effect of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br. Heart J 37 (1975) 1022-1036
2. Waagstein F., Bristow R.M., Swedeberg K., Camerini F., Fowler M.B., Silver M.A., Gilbert E.M., Johnson M.R., Goss F.G., and Hjalmarson A. Beneficial effects of metoprodol in idiopathic dilated cardiomyopathy. Lancet 342 (1993) 1441-1446
3. CIBIS. A randomized trial of β-blockade in heart failure. The Cardiac Insufficiency Bisopriol Study (CIBIS). Circulation 90 (1994) 1765-1773
4. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., and Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N. Engl. J. Med 334 (1996) 1349-1355
5. Feuerstein G.Z., Poste G., and Ruffolo Jr. R.R. Carvedilol Update III: Rationale for use in congestive heart failure. Drugs Today 31 (1995) 307-326
6. Olsen S.L., Gilbert E.M., Renlund D.G., Taylor D.O., Yanowitz F.D., and Bristow M.R. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study. J. Am. Coll. Cardiol 25 (1995) 1225-1231
7. Metra M., Nardi M., Giubbini R., and Cas L.D. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol 24 (1994) 1678-1687
8. Krum H., Sackner-Bernstein J.D., Goldsmith R.L., Kukin M.L., Schwartz B., Penn J., Medina N., Yushak M., Horn E., Katz S.D., Levin H.R., Neuberg G.W., DeLong G., and Packer M. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 92 (1995) 1499-1506
9. Australia-New Zealand Heart Failure Research Collaborative Group. Effects of carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 92 (1995) 212-218